HU9301819D0 - Medical preparatives contqining polyaminic active agents bound to ion-exchanging resin - Google Patents

Medical preparatives contqining polyaminic active agents bound to ion-exchanging resin

Info

Publication number
HU9301819D0
HU9301819D0 HU931819A HUP9301819A HU9301819D0 HU 9301819 D0 HU9301819 D0 HU 9301819D0 HU 931819 A HU931819 A HU 931819A HU P9301819 A HUP9301819 A HU P9301819A HU 9301819 D0 HU9301819 D0 HU 9301819D0
Authority
HU
Hungary
Prior art keywords
contqining
polyaminic
ion
active agents
agents bound
Prior art date
Application number
HU931819A
Other languages
English (en)
Inventor
William Joseph Kelleher
Anthony Earl Carpanzano
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of HU9301819D0 publication Critical patent/HU9301819D0/hu
Publication of HUT74642A publication Critical patent/HUT74642A/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9301819A 1990-12-21 1991-12-16 Polyamine drug-resin complex HUT74642A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63229090A 1990-12-21 1990-12-21

Publications (2)

Publication Number Publication Date
HU9301819D0 true HU9301819D0 (en) 1993-09-28
HUT74642A HUT74642A (en) 1997-01-28

Family

ID=24534913

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9301819A HUT74642A (en) 1990-12-21 1991-12-16 Polyamine drug-resin complex

Country Status (17)

Country Link
EP (1) EP0563294A1 (hu)
JP (1) JPH06504059A (hu)
CN (1) CN1063221A (hu)
AU (1) AU663695B2 (hu)
BR (1) BR9107173A (hu)
CA (1) CA2098200A1 (hu)
CZ (1) CZ119793A3 (hu)
FI (1) FI932842A (hu)
HU (1) HUT74642A (hu)
IE (1) IE914513A1 (hu)
MX (1) MX9102753A (hu)
MY (1) MY107811A (hu)
NO (1) NO932212L (hu)
NZ (1) NZ241097A (hu)
PT (1) PT99912A (hu)
SK (1) SK59493A3 (hu)
WO (1) WO1992011038A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005161A1 (en) * 1993-08-13 1995-02-23 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
EP0727984B1 (en) * 1993-11-18 2003-06-25 Sirtex Medical Limited Controlled release preparation
ES2097087B1 (es) * 1994-08-01 1997-12-16 Univ Sevilla Sistema de liberacion controlada de morfina y otros farmacos solubles en agua por complejacion con sustancias polimericas.
WO1998027961A2 (en) * 1996-12-20 1998-07-02 Warner Lambert Company Antitussive drugs delivered by partially coated ion exchange resins
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
KR20020016069A (ko) * 2000-08-24 2002-03-04 민경윤 마크로라이드계 항생제의 경구투여용 조성물 및 이의 제조방법
EP1667658A2 (en) * 2003-09-03 2006-06-14 Mallinckrodt Inc. Granular sustained release preparation and production thereof
CN100411629C (zh) * 2006-08-28 2008-08-20 浙江大学 一种缓释型补铁剂的制备方法
CN100415297C (zh) * 2006-08-28 2008-09-03 浙江大学 基于阳离子交换树脂的锌补充剂的制备方法
EP2500016A1 (en) 2011-03-18 2012-09-19 Laboratorios Del. Dr. Esteve, S.A. Doxylamine resinate complex
WO2015076821A1 (en) * 2013-11-22 2015-05-28 Tris Pharma, Inc. Novel clonidine formulation
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
FR2634377B1 (fr) * 1988-06-30 1991-09-27 Cortial Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes

Also Published As

Publication number Publication date
BR9107173A (pt) 1993-11-16
AU663695B2 (en) 1995-10-19
FI932842A0 (fi) 1993-06-18
CA2098200A1 (en) 1992-06-21
IE914513A1 (en) 1992-07-01
PT99912A (pt) 1993-01-29
NO932212L (no) 1993-08-20
CN1063221A (zh) 1992-08-05
WO1992011038A1 (en) 1992-07-09
MY107811A (en) 1996-06-29
MX9102753A (es) 1992-06-30
NO932212D0 (no) 1993-06-16
CZ119793A3 (en) 1994-01-19
HUT74642A (en) 1997-01-28
EP0563294A1 (en) 1993-10-06
FI932842A (fi) 1993-06-18
NZ241097A (en) 1994-11-25
JPH06504059A (ja) 1994-05-12
SK59493A3 (en) 1993-11-10
AU9168791A (en) 1992-07-22

Similar Documents

Publication Publication Date Title
EP0444451A3 (en) 3-arylcarbonyl-1h-indoles useful as therapeutic agents
HU9301819D0 (en) Medical preparatives contqining polyaminic active agents bound to ion-exchanging resin
GB9010404D0 (en) Therapeutic agents
GB9018139D0 (en) Therapeutic agents
GB9000725D0 (en) Therapeutic agents
GB9004260D0 (en) Therapeutic agents
GB9014061D0 (en) Therapeutic agents
GB9019833D0 (en) Therapeutic agents
GB9019409D0 (en) Therapeutic agents
GB9016655D0 (en) Therapeutic agents
GB9015524D0 (en) Therapeutic agents
GB9002423D0 (en) Therapeutic agents
GB9007837D0 (en) Therapeutic agents
IE900966L (en) Medicament containing acetylcysteine
GB9003732D0 (en) Therapeutic agents
GB9022538D0 (en) Therapeutic agents
GB9000303D0 (en) Therapeutic agents
GB9002426D0 (en) Therapeutic agents
GB9002427D0 (en) Therapeutic agents
GB9002428D0 (en) Therapeutic agents
GB9002429D0 (en) Therapeutic agents
GB9002315D0 (en) Therapeutic agents
GB9002314D0 (en) Therapeutic agents
GB9004900D0 (en) Therapeutic agents
GB9010791D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment